Among these proteins, the viral structural S protein is highly immunogenic, and the generation of binding and neutralizing antibodies against S protein during natural infection and after vaccination against SARS-CoV-2 has been the focus of extensive investigation [8–10]. This evidence concerns the gene PROS1 and infection.